BioSpace News Archive

GlobalMed, a leading provider of virtual health solutions, today announced that it will showcase integration enhancements to its virtual health platform eNcounter®, introduce a backpack telehealth exam station, and offer a lighter, more affordable exam camera at HIMSS20, March 9-13 in Orlando, FL.

Feb. 26, 2020 15:30 UTC REDWOOD CITY, Calif.--( BUSINESS WIRE )-- Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, today announced that Daniel Florin has joined its Board of Directors. Mr. Florin has been serving as Executive Vice President at Zimmer Biomet Holdings Inc. since July 2019 (NYSE: ZBH). Previously, he served as Executive Vice President and Chief Financial Officer of Z

Contrast&Care®, Dose&Care® heighten performance, increase productivity, and improve patient care, while IBM Watson Imaging Patient Synopsis provides relevant patient information to Radiologists to help inform clinical care decisions.

Those suffering from advanced neck and arm pain may find themselves to be candidates for a new clinical trial that has opened up just this week at the Los Angeles-based practice, Lanman Spinal Neurosurgery, founded by one of the world’s most prominent spinal surgeons, Dr. Todd H. Lanman.

In a release issued under the same headline issued earlier by Harvard Bioscience, Inc., please note that the table titled “Consolidated Statements of Operations” had incorrect data in the first data column.

A new treatment has been found to be successful in improving the vision of partially blind patients.

Multi-year commitment aims to help offset drivers of health disparities such as access to care, education, economic opportunity and the physical environment

Further to my previous statements, as Chief Public Health Officer, I have assessed individuals in quarantine at the NAV CENTRE pursuant to an Emergency Order under the Quarantine Act and determined that they do not pose a risk of significant harm to public health.

A research team led by Dr. Yunching Chen and Tsai-Te Lu of National Tsing Hua University have recently developed a new treatment for cancer, in which blood vessels within malignant tumors are normalized by injecting a specially developed nanodelivery system for nitric oxide, which also facilitates the delivery of cancer drugs and immunocytes into the tumor.

Outlook Therapeutics, Inc. announced that it has closed its previously-announced registered direct offering priced at-the-market under Nasdaq rules of 7,598,426 shares of its common stock, at a combined purchase price of $1.016 per share and associated unregistered warrant, for aggregate gross proceeds of approximately $7.72 million.